Delayed Colorectal Cancer Care During Coronavirus Disease (COVID-19) Pandemic (DECOR-19)

Surgery Clinical Trial

— DECOR-19  

Official title:

DElayed COloRectal Cancer Care During Coronavirus Disease (COVID-19) Pandemic (DECOR-19)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04488549
• Other study ID #: Treviso
• Status: Completed
• Start date: May 20, 2020
• Est. completion date: June 10, 2020

Study information

• Verified date: July 2020
• Source: Treviso Regional Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

To understand and analyse the global impact of COVID-19 on outpatient services, inpatient care, elective surgery, and perioperative colorectal cancer care, a DElayed COloRectal cancer surgery (DECOR-19) survey was conducted in collaboration with numerous international colorectal societies with the objective of obtaining several learning points from the impact of the COVID-19 outbreak on our colorectal cancer patients which will assist us in the ongoing management of our colorectal cancer patients and to provide us safe oncological pathways for future outbreaks.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1051
• Est. completion date: June 10, 2020
• Est. primary completion date: June 10, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Members of renowned scientific societies with an interest in coloproctology

Exclusion Criteria:

• None

Related Conditions & MeSH terms

• Colo-rectal Cancer
• Colon Cancer
• Oncology
• Rectal Cancer
• Rectal Neoplasms
• Surgery

Intervention

Other:
• Survey
International E-survey

Locations

Country	Name	City	State
Italy	Treviso Regional Hospital	Treviso

Sponsors (3)

Lead Sponsor	Collaborator
Treviso Regional Hospital	Gaetano Gallo, Gian Luca Di Tanna

Country where clinical trial is conducted

Italy, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Predictive power of respondents' and hospitals' demographics on delaying colorectal cancer care across 6 geographical regions	Respondents' and hospitals' demographics include: gender, country of origin, type of hospital (i.e. academic or not), type of unit (general surgery vs. colorectal), no. hospital beds, no. yearly surgeries for colon and rectal cancer, hospital preparedness to the emergency (i.e. fully or partially dedicated or not involved in COVID-19 care), readily availability of external facilities for colorectal cancer surgery, cancer care coordinator, personal protective equipment, status of elective surgery, no. elective colorectal cancer patients needing urgent surgery, any change in the original management plan, no. colorectal cancer patients refusing surgery or being COVID-19 + on surgery or becoming COVID-19 + post-operatively, no. staff members quarantined or relocated in COVID-19 units, MDT meeting suspension, any delay in endoscopy, radiology, oncology, surgery, histopathology.	20 days